Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
about
Microtubule-associated protein 1b is required for shaping the neural tubeWnt signaling networks in autism spectrum disorder and intellectual disabilityWnt7a signaling promotes dendritic spine growth and synaptic strength through Ca²⁺/Calmodulin-dependent protein kinase IICellular plasticity cascades in the pathophysiology and treatment of bipolar disorderThe ups and downs of Wnt signaling in prevalent neurological disordersLithium and bipolar mood disorder: the inositol-depletion hypothesis revisitedSynergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionValproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cellsHistone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cellsThe inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation.A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubulesInhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cellsGlycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithiumLithium alters the morphology of neurites regenerating from cultured adult spiral ganglion neuronsIs glycogen synthase kinase-3 a central modulator in mood regulation?Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.Genetics and cell biology of building specific synaptic connectivity.Developmental lead exposure alters synaptogenesis through inhibiting canonical Wnt pathway in vivo and in vitro.Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.In vivo reprogramming of astrocytes to neuroblasts in the adult brain.Valproate alters dopamine signaling in association with induction of Par-4 protein expressionA prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individualsComplex genetic architecture of Drosophila aggressive behavior.Functions of GSK-3 Signaling in Development of the Nervous System.GSK3β inhibition promotes synaptogenesis in Drosophila and mammalian neurons.Mood stabilizer psychopharmacologyWNTs in synapse formation and neuronal circuitry.GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.Structure-guided design of a highly selective glycogen synthase kinase-3β inhibitor: a superior neuroprotective pyrazolone showing antimania effectsThe wnt pathway in mood disordersMode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin--developmental effects of valproic acid.Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications.Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.Intracellular signaling pathways pave roads to recovery for mood disorders.Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out miceValproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro modelPhosphorylation Requirement of Murine Leukemia Virus p12.The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease.
P2860
Q27331377-69C9FB49-6369-40C2-AABA-6D3AEAFA2ADAQ28074740-436E24E1-39E0-4B2E-9D4F-F9DC92D019F8Q28114833-BD4E6A3E-6001-4DB7-ADAF-606CC9FFE02BQ28251880-2E235726-A451-4191-B80C-8328F8D6ACEFQ28277009-C8EB8C25-190D-482F-B76D-C8AC8E472CF0Q28294604-68657F91-1E94-42CA-9207-ACA4D1F87986Q28468536-7267D7D3-9027-4F38-B55D-2E35CC18884DQ28482239-9636B017-DC06-4362-91A4-392988054222Q28580239-5D828A68-AC62-4A54-ABE9-928C94857923Q28583817-1DFF8C0C-74C6-4749-A4EA-DE80CAB0C801Q28586223-358203D4-4360-4EC9-96A6-AA271DA8C97FQ28771380-49DDEBBA-3FA7-4441-A048-28E86EF2C6A6Q30362607-7FCBCE45-3862-42F7-A8E7-6F366EF6A0E6Q30429650-6C124C5A-C569-487C-86AF-5C8BECD447FCQ30475816-3D5ACDF8-BF48-4419-968E-9EE00D231E4DQ30480531-5C3152CE-C7AC-44F3-8B17-3704B1255DB1Q33348860-1C581DA9-620A-43E1-BB51-0A3DB00E90D3Q33856410-E0663A64-7C1C-43BC-890C-885273FA7667Q34180376-69EF84B0-9D7A-465C-9CC4-76D2772A8DD0Q34372623-A5D1DEF9-D758-4B94-81A7-65100B921198Q34429621-5B2FE41C-60A9-4BC0-9C9D-F2772146FFBDQ35011452-329F3E88-448B-4B94-8EA6-39170CBB937FQ35131181-44C47E92-F125-4EE1-9873-97489E69D300Q35345349-9315930F-CA3F-4851-A0FD-52C3F43E9FB9Q35564819-02C9B647-510F-4353-817E-9CDC83785270Q35575758-599DD2F4-BEDB-4E0D-BF06-2957167E54E3Q36031634-B3EAF736-5450-4D0F-8F2F-2234AF82AA88Q36049572-9460DC1F-E7C0-48BB-99CF-9025F8EF331EQ36062876-4CE59BA8-97EA-457C-A826-150F09001262Q36096851-4214DA29-EA69-470F-A786-A4D7498CA10DQ36191316-1B9C996B-D023-402F-B447-DBE3DFF47ED9Q36310513-0964E1E6-9F98-42A1-9F1E-B312F769D081Q36370360-BECDD86E-B686-4153-8522-4294EF6A38D2Q36481051-8CE7A92C-0309-4987-88C3-F016C30B4B1CQ36544286-715FA448-B6D3-4720-A0C5-7B52ED1B9C6CQ36939418-31036F3C-628E-4659-B097-6A158BC885FEQ37178371-0F9FC43F-8063-4D6C-A459-3E4A34E780CBQ37441534-B59267BA-1086-49B5-A9F1-D5139FA3A23EQ37448353-4AE448DE-8F64-4BD9-894B-6202C7A1309CQ37642802-C0B05411-80AA-4A80-AB37-BAA303EDE482
P2860
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@en
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@nl
type
label
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@en
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@nl
prefLabel
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@en
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@nl
P2093
P356
P1476
Valproate regulates GSK-3-medi ...... stering in developing neurons.
@en
P2093
Angela Brennan
Anita C Hall
Fiona R Lucas
Karen Cleverley
Robert G Goold
P304
P356
10.1006/MCNE.2002.1117
P577
2002-06-01T00:00:00Z